Detalhe da pesquisa
1.
Author Correction: Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results.
Nat Med;
30(6): 1787, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38649781
2.
Melanoma metastatic to the adrenal gland: An update on the role of adrenalectomy in multidisciplinary management.
J Surg Oncol;
128(2): 313-321, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37010038
3.
Multiplatform Analysis of Intratumoral PTEN Heterogeneity in Melanoma.
J Invest Dermatol;
143(9): 1779-1787.e1, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36871660
4.
Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results.
Nat Med;
29(4): 898-905, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36997799
5.
Author Correction: Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy.
Nature;
613(7945): E3, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36627494
6.
A Pilot Educational Intervention to Support Primary Care Provider Performance of Skin Cancer Examinations.
J Cancer Educ;
38(1): 364-369, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35013902
7.
Changes in outcomes and factors associated with survival in melanoma patients with brain metastases.
Neuro Oncol;
25(7): 1310-1320, 2023 Jul 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36510640
8.
Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma.
Clin Cancer Res;
29(1): 154-164, 2023 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36166093
9.
Musculoskeletal Injuries During U.S. Air Force Special Warfare Training Assessment and Selection, Fiscal Years 2019-2021.
MSMR;
29(8): 2-6, 2022 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36327377
10.
Multi-modal molecular programs regulate melanoma cell state.
Nat Commun;
13(1): 4000, 2022 07 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35810190
11.
Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy.
Nature;
606(7915): 797-803, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35705814
12.
Economic and health care resource utilization burden of central nervous system metastases in patients with metastatic melanoma.
J Manag Care Spec Pharm;
28(3): 342-353, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35199578
13.
Clinical Models to Define Response and Survival With Anti-PD-1 Antibodies Alone or Combined With Ipilimumab in Metastatic Melanoma.
J Clin Oncol;
40(10): 1068-1080, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35143285
14.
Treatment patterns and clinical outcomes for patients with melanoma and central nervous system metastases: A real-world study.
Cancer Med;
11(1): 139-150, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34874127
15.
Cutaneous adverse events in 155 patients with metastatic melanoma consecutively treated with anti-CTLA4 and anti-PD1 combination immunotherapy: Incidence, management, and clinical benefit.
Cancer;
128(5): 975-983, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34724197
16.
Evaluation of Plasma IL-6 in Patients with Melanoma as a Prognostic and Checkpoint Immunotherapy Predictive Biomarker.
J Invest Dermatol;
142(7): 2046-2049.e3, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34952092
17.
Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis.
Eur J Cancer;
162: 22-33, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34952480
18.
Coenzyme A fuels T cell anti-tumor immunity.
Cell Metab;
33(12): 2415-2427.e6, 2021 12 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34879240
19.
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response.
Science;
374(6575): 1632-1640, 2021 Dec 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34941392
20.
Identification of MicroRNA-mRNA Networks in Melanoma and Their Association with PD-1 Checkpoint Blockade Outcomes.
Cancers (Basel);
13(21)2021 Oct 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34771465